氯沙坦对食欲性与厌恶性学习影响的随机对照试验
该随机双盲对照试验在健康志愿者中比较单次50mg氯沙坦与安慰剂对强化学习的影响,采用复合奖赏与惩罚任务同时探测食欲性与厌恶性学习。结果显示氯沙坦在接触新任务环境初期显著降低从厌恶事件(损失)中的学习率,同时保留从正性结果中的学习,选择切换行为呈现相同效应。
要点
- 氯沙坦降低厌恶损失学习率而保留正性结果学习,可能增强暴露疗法的抑制性学习机制。
- 该效应在接触新任务环境初期出现,并在选择切换行为中一致。
- 研究为健康志愿者单次给药,临床转化需进一步验证。
核心结论
- 氯沙坦增强从正性事件相对于负性事件的学习,可能代表一种计算上定义的神经认知机制以增强临床暴露疗效。
研究设计与样本
- 双盲平行设计随机对照试验,健康志愿者随机分配至单次剂量氯沙坦50mg组(n=28)或安慰剂组(n=25),随后执行同时探测食欲性与厌恶性学习的强化学习任务。
主要发现
- 氯沙坦在参与者首次接触新任务环境时显著降低从厌恶事件(损失)中的学习率,同时保留从正性结果中的学习。
- 选择切换行为分析呈现与学习率分析相同的效应。
关键数值与推荐
- 单次剂量氯沙坦50mg(n=28)对比安慰剂(n=25)。
临床怎么用
- 提示氯沙坦可能作为暴露疗法的辅助药物,通过增强正性相对负性事件的学习来改善暴露效果。
局限性
- 研究仅在健康志愿者中进行,样本量有限,单次给药,临床人群中的疗效与安全性未验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Exposure therapy is a first-line treatment for anxiety disorders but remains ineffective in a large proportion of patients. A proposed mechanism of exposure involves inhibitory learning whereby the association between a stimulus and an aversive outcome is suppressed by a new association with an appetitive or neutral outcome. The blood pressure medication losartan augments fear extinction in rodents and may have similar synergistic effects on human exposure therapy, but the exact cognitive mechanisms underlying these effects remain unknown. METHODS: We used a reinforcement learning paradigm with compound rewards and punishments to test the prediction that losartan augments learning from appetitive relative to aversive outcomes. In a double-blind parallel design, healthy volunteers were randomly assigned to single-dose losartan (50 mg) (n = 28) versus placebo (n = 25). Participants then performed a reinforcement learning task, which simultaneously probes appetitive and aversive learning. Participant choice behavior was analyzed using both a standard reinforcement learning model and analysis of choice switching behavior. RESULTS: Losartan significantly reduced learning rates from aversive events (losses) when participants were first exposed to the novel task environment, while preserving learning from positive outcomes. The same effect was seen in choice switching behavior. CONCLUSIONS: This study shows that losartan enhances learning from positive relative to negative events. This effect may represent a computationally defined neurocognitive mechanism by which the drug could enhance the effect of exposure in clinical populations.
引用
- Pulcu E, Shkreli L, Holst CG, et al. The Effects of the Angiotensin II Receptor Antagonist Losartan on Appetitive Versus Aversive Learning: A Randomized Controlled Trial. Biol Psychiatry. 2019. PMID: 31155138. doi:10.1016/j.biopsych.2019.04.010
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。